Category: Pharmaceutical
News: $NPHC  @NutraPharma – Nutra Pharma CEO Rik Deitsch Interviewed by Stockguru.com
Breaking News: @NutraPharma  $NPHC – CEO @Rikdeitsch Interviewed by @StockGuruDotCom
Alder BioPharmaceuticals Appoints Elisabeth A. Sandoval as Chief Commercial Officer
Chimerix to Present at the Morgan Stanley Global Healthcare Conference
Imaging Endpoints Founder Discusses Role in PharmaCyte Biotech’s Unique Approach to Pancreatic Cancer for Upcoming Clinical Trial
Medgenics Acquires Phase 2-Ready CNS Program: NFC-1
Matinas BioPharma Appoints Cochleate Technology Pioneer Raphael J. Mannino, Ph.D., as Senior Vice President and Chief Technology Officer

Portola Pharmaceuticals to Present Preclinical Data with Andexanet Alfa and Factor Xa Inhibitor Edoxaban at European Society of Cardiology Congress 2015

SOUTH SAN FRANCISCO, Aug. 27, 2015 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq: PTLA) today announced that results of a preclinical study of andexanet alfa will be presented in a moderated poster session at the European Society of Cardiology (ESC) 2015 Congress in London, U.K. The study assessed the activity of andexanet alfa in reversing anticoagulation…

Photo Release — Hemispherx Biopharma Posts Photographs of the Ampligen Facility in New Brunswick, New Jersey

NEW BRUNSWICK, N.J., Aug. 27, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) recently hosted a Stockholder Open House in their manufacturing facility in New Brunswick, NJ. During the tour, visitors were taken throughout the Alferon® and Ampligen® manufacturing suites and also via our Research and Development labs, where there has been a significant amount…

Notch3 Biomarker Results and Updated Data From OncoMed’s Phase 1b/2 PINNACLE Clinical Trial Accepted for Presentation at the 16th World Conference on Lung Cancer

REDWOOD CITY, Calif., Aug. 27, 2015 (GLOBE NEWSWIRE) -- New biomarker data related to OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) Phase 1b/2 PINNACLE clinical trial of tarextumab (Anti-Notch 2/3, OMP-59R5) in small cell lung cancer (SCLC) will be presented by academic collaborator, Anne Chiang M.D., Ph.D., of the Yale School of Medicine, during a mini oral discussion…

AGTC Announces Achievement of XLRS Patient Enrollment Milestone in Biogen Collaboration

GAINESVILLE, Fla., Aug. 27, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced it had met a patient enrollment milestone in the X-Linked Retinoschisis (XLRS) clinical study, which will earn AGTC a $5…
Cookeville Medical Center Selects Allscripts for Chronic Care Management (CCM) Program

ScriptRock Appoints Tony Esposito Vice President of Sales

MOUNTAIN VIEW, CALIF., Aug. 24, 2015 (GLOBE NEWSWIRE) -- ScriptRock, the leading solution for integrity monitoring, announced today the appointment of Tony Esposito as Vice President of Sales. With over 28 years of experience in building and leading high performance enterprise software sales teams, Mr. Esposito brings with him a track record of successful leadership…

MediciNova Announces Closing of Underwritten Public Offering of Common Stock

LA JOLLA, Calif., Aug. 24, 2015 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), announced today closing of the previously announced underwritten public offering of 5,000,000 shares of its common stock at a price to the…
Update: RGRX Up 30.77% Since Our Alert 4 Market Days Ago
Breaking: BHRT – Bioheart Inc. Suggests Positive Momentum for Company
Tuesday Trade Alert: Up 147.5% from Recent Lows, Skinvisible (SKVI) is Clearly Breaking Out
52 Week High Alert for Skivisible Inc. (SKVI) as Kintari Gets Closer to Launch
New 52 Week High for Client Skinvisible Inc. $SKVI – Nearly Doubled in Two Weeks
Skinvisible Pharmaceuticals $SKVI adds Key People to #Kintari